Memorial Sloan Kettering Cancer Center: Ovarian Neoplasms trials

The registry lists 39 Ovarian Neoplasms studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 4 are open to participants now and 2 have results posted.

Early Phase 1 2Phase 1 3Phase 2 9Phase 3 2No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study of Isoquercetin in People With Ovarian CancerRecruitingNCT07303894Phase 2
• Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryRecruitingNCT06290193Phase 2
• A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)RecruitingNCT05429970Not applicable
• Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsRecruitingNCT04751435Not applicable
• TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian CancerCompletedNCT02764333Phase 2Results posted
• Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT01767675Phase 2Results posted
• A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of ChemotherapyActive, not recruitingNCT06240598Phase 2
• A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerActive, not recruitingNCT05053230Not applicable
• A Study of Intra-operative Imaging in Women With Ovarian CancerActive, not recruitingNCT04878094Phase 3
• Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian CancerActive, not recruitingNCT04454450Not applicable
• Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant ChemotherapyActive, not recruitingNCT04204811Not applicable
• ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility StudyCompletedNCT04051502Early Phase 1
• Continued Access to RXDX-105CompletedNCT03784378Phase 1
• Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative StudyCompletedNCT02928549
• Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
• A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian CancerCompletedNCT02737787Phase 1
• Yoga Practice for Breast or Ovarian Cancer PatientsCompletedNCT02305498Not applicable
• Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And GenomicsCompletedNCT02144311Not applicable
• Structural and Functional Imaging and Cognitive Functions in Ovarian CancerCompletedNCT01591772
• Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian CancerCompletedNCT01471483
• Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian CancerCompletedNCT01442051Not applicable
• Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation TherapyActive, not recruitingNCT01223248Phase 3
• Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot StudyCompletedNCT00946140
• Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer RiskCompletedNCT00735150
• Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.CompletedNCT00620243Early Phase 1
• Sexual Functioning After Primary Treatment of Ovarian CancerTerminatedNCT00596544
• Women Surviving Ovarian CancerCompletedNCT00596349
• Estrogen, Diet, Genetics and Endometrial CancerActive, not recruitingNCT00587886
• A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian CancerCompletedNCT00587093Not applicable
• Genetic Studies in Breast CancerCompletedNCT00582322
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer PatientsActive, not recruitingNCT00579514Not applicable
• Clinical Significance of Germline BRCA MutationsActive, not recruitingNCT00579488
• Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersActive, not recruitingNCT00579163
• An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing RadiationCompletedNCT00132704
• Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00028912Phase 1
• TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerCompletedNCT00022347Phase 2
• Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian CancerCompletedNCT00016224Phase 2
• Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNCT00003345Phase 2
• Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian CancerCompletedNCT00002928Phase 2